Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Vawe‐AQ Injection

Prescription Icon
Prescription Required

Marketer

Onechem Pharmaceuticals

Salt Composition

Diclofenac (75mg)

Overview Vawe‐AQ Injection

Aquavet Injection provides analgesia. Indicated for pain, inflammation, rigidity, and arthralgia associated with rheumatoid arthritis, osteoarthritis, and acute musculoskeletal trauma, it's administered parenterally when oral routes are infeasible. Injection must be performed by a qualified medical professional; self-administration is strictly prohibited. Prior history of cardiovascular events (heart disease or stroke) should be disclosed to your physician. Report any injection site reactions (pain, edema, erythema) immediately. Common adverse effects encompass nausea, emesis, cephalalgia, and local injection site responses. Prolonged therapy may necessitate regular monitoring of renal and hepatic function, along with hematological parameters. Chronic use carries a risk of severe complications including gastrointestinal hemorrhage and nephropathy.

Uses of Vawe‐AQ Injection

Analgesia

Major Benefits of Vawe‐AQ Injection:

Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.

Common Side effects of Vawe‐AQ Injection:

  • Injection site reactions (pain, swelling, redness)
  • Vomiting
  • Flatulence
  • Edema (swelling)
  • Nausea
  • Headache
  • Dizziness

How to use Vawe‐AQ Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Vawe‐AQ Injection works:

AquaVein injection, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for pain and associated symptoms such as redness and edema.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when using Vawe‐AQ Injection concurrently with alcohol. Physician consultation is recommended.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Vawe-AQ Injection during pregnancy is contraindicated due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Vawe-AQ Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Administering Vawe-AQ Injection may impair driving ability due to potential adverse reactions.

KidneyKidneyCAUTION

Careful consideration should be given to administering Vawe-AQ Injection to individuals with impaired renal function. Dosage modification of Vawe-AQ Injection might be necessary. Physician consultation is advised.

LiverLiverCAUTION

Individuals with hepatic impairment should use Vawe-AQ Injection judiciously. Dosage modification of Vawe-AQ Injection might be necessary. Physician consultation is advised.

What if you forget to take Vawe‐AQ Injection :

Omit a Vawe-AQ Injection dose? Seek your physician's advice.

Facts to Know About Vawe‐AQ Injection

LabelValue
Chemical Type Phenylacetic acid derivative
Developing Habits No.
Type of Therapy Pain Relievers

FAQs on Vawe‐AQ Injection

Vawe-AQ Injection must be administered only by a healthcare professional. Intramuscular (preferably in the buttock), subcutaneous, or intravenous bolus injection is acceptable; infusion is not. The prescribed dose must not be exceeded, and treatment should not continue beyond two days.
Vawe-AQ Injection may increase your risk of heart attack or stroke, particularly with higher doses or longer use. It can also cause stomach and intestinal ulcers, bleeding, or perforation, potentially life-threatening and occurring without warning at any time. Seek immediate medical attention if you experience such symptoms.
Vawe-AQ Injection provides effective pain and inflammation relief. Its applications include sprains, strains, other injuries, various arthritic conditions, gout, and post-surgical pain and inflammation.
Using Vawe-AQ Injection long-term or at high doses can lead to kidney issues like blood or protein in the urine and painful urination. Individuals at greatest risk—those dehydrated, with heart failure, impaired kidney function, hypertension, or elderly patients, plus those taking diuretics or other kidney-affecting medications—should have their kidney function monitored.
Vawe-AQ Injection may cause drowsiness, dizziness, fatigue, and visual disturbances, though these side effects are uncommon and may not affect all users. Avoid driving or operating machinery if you experience any of these symptoms.
Avoid Vawe-AQ Injection during pregnancy, especially the last trimester, due to potential harm to the baby and the risk of premature labor. Its use should also be avoided during the first six months. Use in pregnancy is only considered if the potential benefits clearly outweigh the risks. Always consult your doctor before using Vawe-AQ Injection if you are pregnant.
Vawe-AQ Injection is not intoxicating and doesn't pose a risk of abuse or dependence. If you experience any discomfort, contact your physician.
Vawe-AQ Injection is not a narcotic; it's a non-steroidal anti-inflammatory drug (NSAID).
Vawe‐AQ Injection
20
MRP 25
18% off